QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 prophase-labs-entered-into-sales-agreement-with-westpark-capital-relating-to-shares-of-common-stock-offered-by-prospectus-supplement--may-offer-and-sell-shares-of-common-stock-from-time-to-time-up-to-43m

https://www.sec.gov/Archives/edgar/data/868278/000149315225018187/form424b5.htm

 prophase-labs-shareholders-approve-strategic-expansion-including-increase-in-authorized-shares-to-1b

ProPhase Labs Stockholders Deliver Strong Mandate at Special MeetingUNIONDALE, NY, Sept. 12, 2025 (GLOBE NEWSWIRE) -- ProPhase ...

 prophase-labs-q2-eps-011-beats-015-estimate-sales-1247m-may-not-be-comparable-to-3550m-estimate

The Company did not generate any revenues from diagnostic services for the three months ended June 30, 2025 and 2024, respectiv...

 prophase-labs-receives-nasdaq-extension-until-december-2025-to-regain-compliance-with-100-bid-price-requirement

ProPhase Labs Inc. (NASDAQ:PRPH), (the "Company" or "ProPhase") a next generation biotech, genomics and consume...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION